
Case Report Poster: A Smelly Situation
This case presented as part of the Poster Presentations at the 2021 NEI Congress is a good reminder of the importance of taking a thorough history.
CONFERENCE REPORTER
Parul Kumar, MD, and colleagues from Westchester Medical Center,
The patient reported delusions of her father invisibly raping her. She also reported hypoguesia and
Neurological examination was within normal limits, as were brain computed tomography, chest X-ray, and various laboratory studies. However, the patient tested positive for SARS-CoV-2.
Following admission and treatment for 2 days that included aripiprazole, haloperidol, topiramate, and fluoxetine, the patient reported resolution of the hallucinations and was discharged to follow-up outpatient care.
Research has indicated that patients with schizophrenia have an increased risk for acquiring COVID-19, with an adjusted odds ratio of 7.34,1 along with increased risk for hospitalization (27.4% vs 18.6%) and mortality (8.5% vs 4.7%) compared with individuals with no psychiatric disorders, respectively. Kumar et al noted the olfactory symptoms were the only presenting symptoms associated with COVID-19 in their patient. Thus, they recommended testing for SARS-CoV-2 in patients with psychosis or other psychiatric illness who present with olfactory symptoms as part of the differential diagnosis.
Reference
1. Wang Q, Xu R, Volkow ND.
Newsletter
Receive trusted psychiatric news, expert analysis, and clinical insights — subscribe today to support your practice and your patients.